Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2003
08/27/2003CN1438888A 稳定的液体制剂 Stable liquid formulation
08/27/2003CN1438887A 水性液体制剂 The aqueous liquid preparation
08/27/2003CN1438886A Ophthalmic solution
08/27/2003CN1438885A Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators
08/27/2003CN1438884A Therapeutic combinations of fatty acids
08/27/2003CN1438883A Beta Secretase inhibitors
08/27/2003CN1438882A Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents
08/27/2003CN1438880A Method for preparing a composition
08/27/2003CN1438878A Topical pharmaceutical formulations and methods of treatment
08/27/2003CN1438876A Wet milling process
08/27/2003CN1438875A Method for making particles for use in a pharmaceutical composition
08/27/2003CN1438873A Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
08/27/2003CN1438870A Cosmetic compositions containing substituted amine derivatives
08/27/2003CN1438866A Medical product package for eradication therapy
08/27/2003CN1438861A Minimizing adverse experience associated with oxybutynin therapy
08/27/2003CN1438858A Biodegradable vehicles and delivery systems of biologically active substances
08/27/2003CN1438306A Efficient biological lubricant and preparation method
08/27/2003CN1438237A Echinocystic acid preparation methodÒÇümedicinal preparation and new use as medicine
08/27/2003CN1438236A Method for purifying Huanweihuangyangxing D and preparation thereof
08/27/2003CN1438225A Ginger-yellow pigment metal-ion complex, its preparation method and use
08/27/2003CN1438220A 1-(1,2-disubstituted piperidyl)-4-substituted diethylenediamine derivative
08/27/2003CN1438217A Bearing-resisting compound and preparing method
08/27/2003CN1438048A Optical power therapeutic combined device
08/27/2003CN1437991A Medicine for treating bacterial vaginal disease
08/27/2003CN1437965A Ginkgo-leaf small pills
08/27/2003CN1437955A Use of refined fur-seal oil in medicine for preventing and treating climacteric metancholia and menalgia
08/27/2003CN1437954A Nutrient tablet for sobering and protecting liver
08/27/2003CN1437953A Gentiamarin powder infection for muscle injection and intravenous injection
08/27/2003CN1437952A Compound Huanweihuangyangxing D tablet preparation
08/27/2003CN1437951A Anti-tumor function of sophorine and its medicine preparation
08/27/2003CN1437950A Herba florigen oral drip-ball and production method
08/27/2003CN1437949A Use of Rhizoma Dioscoreae Nipponicae and its dioscorea saponin in treating chronic glomerulus nephritis
08/27/2003CN1437948A Composition containing resveratrol and resveratr-glycoside and its use
08/27/2003CN1437947A Ofloxacin eye ointment
08/27/2003CN1437946A Medicine-release system of compound Rifampicin
08/27/2003CN1437945A Central medicine preparation and preparation method
08/27/2003CN1437944A Technology for producing Dekuiluan lozenge
08/27/2003CN1437943A Compound injection of levocarnitine and vitamin B6
08/27/2003CN1437942A Vinorebin powder injection and preparation method
08/27/2003CN1437941A Preparation method for soft capsule of matrine for treating arythmia and acute enteritis
08/27/2003CN1437940A Fluconazole oral tablet capable of quickly disintegrating and dissolving out and preparation process
08/27/2003CN1437939A Method for induding andrographolide by cyclodextrin and medicinal preparation
08/27/2003CN1437938A Use of Sulfocanbamide derivative in medicine for treating eye yellow spot variation
08/27/2003CN1437937A Use of amfetamine alcohol compounds as medicine for treating hepatitis B and preparation method thereof
08/27/2003CN1437936A Libaweilin slow-released pill
08/27/2003CN1437935A Method for preparing medicine for relieving cough and reducing sputum
08/27/2003CN1437933A Method for preparing Rifampiciu microballs covered by degradable high-molecular material
08/27/2003CN1437931A Coenzyme Q10 precursor liposome and preparation method
08/27/2003CN1119421C Recombinant fusion proteins to growth hormone and serum albumin
08/27/2003CN1119351C Cyclic adhesion inhibitors
08/27/2003CN1119348C Glucocorticoid derivatives, their composition and use
08/27/2003CN1119346C Benzothiadiaxoles and derivatives
08/27/2003CN1119345C Benzo (5,6) cycloheptapyridine compounds use furl as farnesyl protein transferase inhibitors
08/27/2003CN1119344C Heterocyclic substed, pyrrolidine amide derivatives
08/27/2003CN1119340C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
08/27/2003CN1119336C Novel compounds with analgesic effect
08/27/2003CN1119334C Substsituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of disease charaterized by abnomal cell proliferation
08/27/2003CN1119328C Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
08/27/2003CN1119313C Inhibition of matrix metallo proteases by 2-(omega-aroylalkyc)-4-biaryl-oxobutyric acids
08/27/2003CN1119170C Use of micrococcin antibiotics for the preparation of pharmaceuticals for treating or preventing mastitis
08/27/2003CN1119169C Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof
08/27/2003CN1119162C Dermatitis ointment and its preparing process
08/27/2003CN1119159C Medicine for curing stomatocase
08/27/2003CN1119151C Preparation of medicine for restoring the normal transmitting function of nerve
08/27/2003CN1119150C Transdermal systems containing two active principles in separate compartments, their method of preparation and application as medicine
08/27/2003CN1119149C 10,11 methanodibenzosuberane derivatives used as chemo sensitizing agents
08/27/2003CN1119148C Use of alpha 1L agonists in treatment of in continence
08/27/2003CN1119147C Kappa-opiate agonists for inflammatory bowel disorders
08/27/2003CN1119146C Compositions and kits for increasing the oral bioavailability of pharmaceutical agents
08/27/2003CN1119145C Liposomal compositions and method of using them
08/26/2003US6611654 Time- and location-driven personalized TV
08/26/2003US6610906 Nucleotide sequences for gene regulation and methods of use thereof
08/26/2003US6610890 Treatment and/or prevention of diabetic complications; such as 3,3',4,4',5,5'-hexabromo-2,2'-dihydroxy-oxydiphenyl
08/26/2003US6610883 Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
08/26/2003US6610877 Treating photo and/or age damaged skin
08/26/2003US6610868 Conjugated linoleic acid compositions and methods of making same
08/26/2003US6610862 Preparation of warfarin sodium from warfarin sodium-2-propanol clathrate by solvent expulsion
08/26/2003US6610860 C7 ester substituted taxanes
08/26/2003US6610858 Antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex; thrombolytic agents
08/26/2003US6610854 Reacting (Z)-5-Fluoro-2-methyl-(4-pyridylidene)-3-(N-benzyl) indenylacetamide with hydrochloric acid to produce (Z)-5-fluoro-2-methyl-(4-pyridylidene)-3-(N-benzyl)indenylacetamide hydrochloride
08/26/2003US6610850 Contrast media for angiography
08/26/2003US6610847 Tyrosine kinase inhibitors; immunosuppressants
08/26/2003US6610842 Removing hydroxyl protecting group from compound of given formula and treating with another compound; wide range of diagnostic and therapeutic uses
08/26/2003US6610839 Promoter for telomerase reverse transcriptase
08/26/2003US6610820 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
08/26/2003US6610750 Rhein or an ester
08/26/2003US6610749 A method for reducing food intake in a subject and a method for reducing the levels of an endocrine in a subject
08/26/2003US6610747 Phenoxybenzylamine derivatives as SSRIs
08/26/2003US6610746 Treating non-insulin dependent diabetes mellitus, insulin resistance, Syndrome X, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic cardiomyopathy, polycystic ovary syndrome, cataracts and hyperglycemia; kits
08/26/2003US6610745 Use of 2-hydroxy-4-trifluoromethyl-benzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor NF-KS
08/26/2003US6610744 Methods of treatment with compounds having RARα receptor specific or selective activity
08/26/2003US6610743 Bicyclic metabotropic glutamate receptor ligands
08/26/2003US6610742 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
08/26/2003US6610740 A nutritional, cosmetic or pharmaceutical formulation comprising esters of polyethylene glycol
08/26/2003US6610739 Amide and ester derivatives
08/26/2003US6610737 Non-psychotropic cannabinoids
08/26/2003US6610736 16-Halogen-epothilone derivatives, method for producing them and their pharmaceutical use
08/26/2003US6610735 Coadministration of a an oral bioavailability-enhancing agent (e.g., a cyclosporin F or ketoconazole) with a drug that exhibits poor or inconsistent oral bioavailability (e.g., paclitaxel, docetaxel or etoposide)
08/26/2003US6610734 Heterocyclic sulfonamide inhibitors of beta amyloid production
08/26/2003US6610732 For relieving or preventing constipation in a human constipated patient or preparing a bowel prior to preventative, diagnostic or surgical procedures
1 ... 5364 5365 5366 5367 5368 5369 5370 5371 5372 5373 5374 5375 5376 5377 5378 5379 5380 5381 5382 5383 5384 ... 7860